Javascript must be enabled to continue!
Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts
View through CrossRef
Formation of intrahepatic bile ducts (IHBDs) proceeds in accordance with their microenvironment. Particularly, mesenchymal cells around portal veins regulate the differentiation and ductular morphogenesis of cholangiocytes in the developing liver; however, further studies are needed to fully understand the arrangement of IHBDs into a continuous hierarchical network. This study aims to clarify the interaction between biliary and liver mesenchymal cells during IHBD formation. To identify candidate factors contributing to this cell–cell interaction, mesenchymal cells were isolated from embryonic day 16.5 matrix metalloproteinase 14 (MMP14)‐deficient (knockout [KO]) mice livers, in which IHBD formation is retarded, and compared with those of the wild type (WT). WT mesenchymal cells significantly facilitated the formation of luminal structures comprised of hepatoblast‐derived cholangiocytes (cholangiocytic cysts), whereas MMP14‐KO mesenchymal cells failed to promote cyst formation. Comprehensive analysis revealed that expression of vasoactive intestinal peptide (VIP) was significantly suppressed in MMP14‐KO mesenchymal cells. VIP and VIP receptor 1 (VIPR1) were mainly expressed in periportal mesenchymal cells and cholangiocytic progenitors during IHBD development, respectively, in vivo. VIP/VIPR1 signaling significantly encouraged cholangiocytic cyst formation and up‐regulated tight junction protein 1, cystic fibrosis transmembrane conductance regulator, and aquaporin 1, in vitro. VIP antagonist significantly suppressed the tight junction assembly and the up‐regulation of ion/water transporters during IHBD development in vivo. In a cholestatic injury model of adult mice, exogenous VIP administration promoted the restoration of damaged tight junctions in bile ducts and improved hyperbilirubinemia. Conclusion: VIP is produced by periportal mesenchymal cells during the perinatal stage. It supports bile duct development by establishing tight junctions and up‐regulating ion/water transporters in cholangiocytes. VIP contributes to prompt recovery from cholestatic damage through the establishment of tight junctions in the bile ducts.
Ovid Technologies (Wolters Kluwer Health)
Ayako Sato
Sei Kakinuma
Masato Miyoshi
Akihide Kamiya
Tomoyuki Tsunoda
Shun Kaneko
Jun Tsuchiya
Taro Shimizu
Eiko Takeichi
Sayuri Nitta
Fukiko Kawai‐Kitahata
Miyako Murakawa
Yasuhiro Itsui
Mina Nakagawa
Seishin Azuma
Naohiko Koshikawa
Motoharu Seiki
Hiromitsu Nakauchi
Yasuhiro Asahina
Mamoru Watanabe
Title: Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts
Description:
Formation of intrahepatic bile ducts (IHBDs) proceeds in accordance with their microenvironment.
Particularly, mesenchymal cells around portal veins regulate the differentiation and ductular morphogenesis of cholangiocytes in the developing liver; however, further studies are needed to fully understand the arrangement of IHBDs into a continuous hierarchical network.
This study aims to clarify the interaction between biliary and liver mesenchymal cells during IHBD formation.
To identify candidate factors contributing to this cell–cell interaction, mesenchymal cells were isolated from embryonic day 16.
5 matrix metalloproteinase 14 (MMP14)‐deficient (knockout [KO]) mice livers, in which IHBD formation is retarded, and compared with those of the wild type (WT).
WT mesenchymal cells significantly facilitated the formation of luminal structures comprised of hepatoblast‐derived cholangiocytes (cholangiocytic cysts), whereas MMP14‐KO mesenchymal cells failed to promote cyst formation.
Comprehensive analysis revealed that expression of vasoactive intestinal peptide (VIP) was significantly suppressed in MMP14‐KO mesenchymal cells.
VIP and VIP receptor 1 (VIPR1) were mainly expressed in periportal mesenchymal cells and cholangiocytic progenitors during IHBD development, respectively, in vivo.
VIP/VIPR1 signaling significantly encouraged cholangiocytic cyst formation and up‐regulated tight junction protein 1, cystic fibrosis transmembrane conductance regulator, and aquaporin 1, in vitro.
VIP antagonist significantly suppressed the tight junction assembly and the up‐regulation of ion/water transporters during IHBD development in vivo.
In a cholestatic injury model of adult mice, exogenous VIP administration promoted the restoration of damaged tight junctions in bile ducts and improved hyperbilirubinemia.
Conclusion: VIP is produced by periportal mesenchymal cells during the perinatal stage.
It supports bile duct development by establishing tight junctions and up‐regulating ion/water transporters in cholangiocytes.
VIP contributes to prompt recovery from cholestatic damage through the establishment of tight junctions in the bile ducts.
Related Results
THE BIOLOGICAL SIGNIFICANCE OF CHEMICAL DIFFERENCES IN BILE SALTS
THE BIOLOGICAL SIGNIFICANCE OF CHEMICAL DIFFERENCES IN BILE SALTS
Summary1. The chemical nature of the bile salts is a character that must be under the control of several genes and is also affected by intestinal micro‐organisms and perhaps again ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide
Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide
1. Gastric sodium loading causes release of vasoactive intestinal peptide from the gastrointestinal tract and, in rabbits on a low-sodium diet, an apparent decrease in metabolism o...
Bile Salt Structure and Phase Equilibria in Aqueous Bile Salt and Bile Salt-Lecithin Systems
Bile Salt Structure and Phase Equilibria in Aqueous Bile Salt and Bile Salt-Lecithin Systems
The hydrophilic-hydrophobic balance of bile salt monomers can be readily quantified by their elution sequence during reverse-phase high-performance liquid chromatography. Such stud...
Global transcriptome analysis reveals
Salmonella
Typhimurium employs the nitrate-dependent anaerobic pathway to combat bile stress
Global transcriptome analysis reveals
Salmonella
Typhimurium employs the nitrate-dependent anaerobic pathway to combat bile stress
Abstract
Salmonella
Typhimurium is an enteric pathogen that is highly tolerant to bile. Next-generation mRNA sequencing was per...
RECONSTRUCTION OF THE FEMALE UROGENITAL COMPLEX IN THE PRENATAL PERIOD OF ONTOGENESIS
RECONSTRUCTION OF THE FEMALE UROGENITAL COMPLEX IN THE PRENATAL PERIOD OF ONTOGENESIS
In 9-weeks prefetuses, urogenital complexes are located lower than in prefetuses of previous age groups. In the vertical sections of the urogenital cords, the paramesonephric ducts...
Cell-free scaffold for regenerating defective bile ducts
Cell-free scaffold for regenerating defective bile ducts
Abstract
Much research has focussed on restoring the defective part of the gastrointestinal tract, which is considered the best way to preserve function. However, to date, ...

